Mechanisms, impact and management of pain in rheumatoid arthritis

被引:218
作者
Walsh, David A. [1 ]
McWilliams, Daniel F. [1 ]
机构
[1] Univ Nottingham, City Hosp, Acad Rheumatol, Arthrit Res UK Pain Ctr, Nottingham NG5 1PB, England
关键词
QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; TEMPOROMANDIBULAR-JOINT; DISEASE-ACTIVITY; SPINAL-CORD; INFLAMMATORY ARTHRITIS; CENTRAL SENSITIZATION; COPING STRATEGIES; PHYSICAL-ACTIVITY; NEUROPATHIC PAIN;
D O I
10.1038/nrrheum.2014.64
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
People with rheumatoid arthritis (RA) identify pain as their most important symptom, one that often persists despite optimal control of inflammatory disease. RA pain arises from multiple mechanisms, involving inflammation, peripheral and central pain processing and, with disease progression, structural change within the joint. Consequently, RA pain has a wide range of characteristics-constant or intermittent, localized or widespread-and is often associated with psychological distress and fatigue. Dominant pain mechanisms in an individual are identified by critical evaluation of clinical symptoms and signs, and by laboratory and imaging tests. Understanding these mechanisms is essential for effective management, although evidence from preclinical models should be interpreted with caution. A range of pharmacological analgesic and immunomodulatory agents, psychological interventions and surgery may help manage RA pain. Pain contributes importantly to the clinical assessment of inflammatory disease activity, and noninflammatory components of RA pain should be considered when gauging eligibility for or response to biologic agents. Further randomized controlled trials are required to determine the optimal usage of analgesics in RA, and novel agents with greater efficacy and lower propensity for adverse events are urgently needed. Meanwhile, targeted use of existing treatments could reduce pain in people with RA.
引用
收藏
页码:581 / 592
页数:12
相关论文
共 172 条
[1]  
ABBADIE C, 1994, J NEUROSCI, V14, P5865
[2]   Treatment strategies in recent onset rheumatoid arthritis [J].
Allaart, Cornelia F. ;
Huizinga, Tom W. J. .
CURRENT OPINION IN RHEUMATOLOGY, 2011, 23 (03) :241-244
[3]   A Key Role for gp130 Expressed on Peripheral Sensory Nerves in Pathological Pain [J].
Andratsch, Manfred ;
Mair, Norbert ;
Constantin, Cristina E. ;
Scherbakov, Nadja ;
Benetti, Camilla ;
Quarta, Serena ;
Vogl, Christian ;
Sailer, Claudia A. ;
Ueceyler, Nurcan ;
Brockhaus, Johannes ;
Martini, Rudolf ;
Sommer, Claudia ;
Zeilhofer, Hanns Ulrich ;
Mueller, Werner ;
Kuner, Rohini ;
Davis, John B. ;
Rose-John, Stefan ;
Kress, Michaela .
JOURNAL OF NEUROSCIENCE, 2009, 29 (43) :13473-13483
[4]   Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases [J].
Antonelli, Alessandro ;
Ferrari, Silvia Martina ;
Giuggioli, Dilia ;
Ferrannini, Ele ;
Ferri, Clodoveo ;
Fallahi, Poupak .
AUTOIMMUNITY REVIEWS, 2014, 13 (03) :272-280
[5]  
Arendt-Nielsen L., 1995, EUR J ANAESTHESIOL S, V10, P1
[6]   Efficacy of Cardiorespiratory Aerobic Exercise in Rheumatoid Arthritis: Meta-Analysis of Randomized Controlled Trials [J].
Baillet, Athan ;
Zeboulon, Nadine ;
Gossec, Laure ;
Combescure, Christophe ;
Bodin, Louis-Antoine ;
Juvin, Robert ;
Dougados, Maxime ;
Gaudin, Philippe .
ARTHRITIS CARE & RESEARCH, 2010, 62 (07) :984-992
[7]   Adjuvant-induced arthritis:: IL-1β, IL-6 and TNF-α are up-regulated in the spinal cord [J].
Bao, L ;
Zhu, Y ;
Elhassan, AM ;
Wu, QY ;
Xiao, BG ;
Zhu, J ;
Lindgren, JU .
NEUROREPORT, 2001, 12 (18) :3905-3908
[8]  
BELZA BL, 1995, J RHEUMATOL, V22, P639
[9]   Stress and the inflammatory response: A review of neurogenic inflammation [J].
Black, PH .
BRAIN BEHAVIOR AND IMMUNITY, 2002, 16 (06) :622-653
[10]  
BLYTH T, 1994, BRIT J RHEUMATOL, V33, P461